Jantunen J, et al. - Researchers studied the co-occurrence of various allergic diseases in asthma and allergy patients, as well as they, assessed the use of medication and drug and healthcare costs via Nationwide Allergy Barometer Survey in the Finnish pharmacies. They concluded that multimorbidity and polypharmacy represent major concerns in asthma and allergy. Multimorbidity led to increased disease severity, drug use, and costs. On average, 3.8 drugs with the annual costs of EUR 661, were used by the asthmatics. Whereas, asthmatics with multimorbidity used 4.9 drugs with the annual costs of EUR 847. A better integrated and more comprehensive allergy management was recommended to attenuate the burden.